Abstract
Simple, precise, and stability-indicating reversed-phase liquid chromatography (RP-LC) method was developed and validated for simultaneous determination of delapril (DEL) and manidipine (MAN) in pharmaceutical dosage form, using the Plackett-Burman experimental design for robustness evaluation. The LC method was carried out on a C8 column (250 mm × 4.6 mm i.d., 5 µm), maintained at 35°C. The mobile-phase consisted of acetonitrile and a solution of triethylamine 0.3% pH 3.0 (adjusted with phosphoric acid) (55:45; v/v), run at a flow rate of 1.2 mL · min−1 and using photodiode array (PDA) detection at 220 nm. The chromatographic separation was obtained within 7 min and was linear in the range of 3–120 µg · mL−1 (r2 = 0.9997) for DEL and 1–40 µg · mL−1 (r2 = 0.9998) for MAN. Validation parameters such as the specificity, linearity, precision, accuracy, and robustness were evaluated, giving results within the acceptable range. Stress studies were carried out and no interference of the degradation products was detected. The proposed method was successfully applied for the simultaneous quantitative analysis of DEL and MAN in the tablet dosage form, contributing to improve the quality control and to assure the therapeutic efficacy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Liquid Chromatography & Related Technologies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
